Talecris Biotherapeutics to Report Third Quarter 2009 Financial Results

RESEARCH TRIANGLE PARK, N.C.--(Business Wire)--
Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will release its third
quarter 2009 financial results on November 9, 2009, after the stock market
closes, and will host a conference call at 8:30 AM Eastern Time on November 10,
2009.

Investors and analysts may participate via phone by calling 1-888-713-4199
(domestic) or 1-617-213-4861 (international), passcode number 28819752. To
ensure timely access, please dial into the call approximately 10 minutes before
it is scheduled to begin. The listen-only webcast will also be available through
the Investor Relations section of http://www.talecris.com.

Participants may pre-register for the conference call at
https://www.theconferencingservice.com/prereg/key.process?key=PK6K9WQT6.
Pre-registrants will be issued a PIN number to use when dialing into the live
call which will provide quick access to the conference by bypassing the operator
upon connection.

A replay of the conference call will be available beginning approximately two
hours after the call concludes and remain accessible until November 17, 2009 by
dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international), passcode
number 19852415. The webcast of the conference call will be archived on the
Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company
that discovers, develops and produces critical care treatments for people with
life-threatening disorders in a variety of therapeutic areas including
immunology, pulmonology, neurology and hemostasis.

Brunswick Group
Susan Stillings / Greg Faje, 212-333-3810
or
Talecris Investor Relations
John Hanson, 919-316-6139
Chief Financial Officer
investor.relations@talecris.com
or
Talecris Corporate Communications
Becky Levine, 919-316-6590
becky.levine@talecris.com

Copyright Business Wire 2009